Navigation Links
DrugRisk Announces Launch of DePuy Hip Resource Center
Date:4/9/2013

Houston, TX (PRWEB) April 09, 2013

The medical implant safety advocates at DrugRisk.com are announcing the launch of a new resource center for patients affected by the recall of the DePuy ASR and other metal hips. The site will contain the latest warnings, recalls, studies and litigation news.

DrugRisk was created to improve the safety of patients using popular drugs and medical devices. Visitors can learn if others are experiencing similar side effects and decide if they need legal advice.

The resource center contains warnings from the British Medical Journal* and FDA** that toxic metal shavings from all-metal hips like the DePuy ASR can cause serious conditions such as tissue damage, bone loss and damage to other organs when released into the body.

DePuy’s 2010 recall of their ASR metal hip indicated as many as 13% of patients may require revision surgery***. However, studies now show the rate could be as high as 44%****. Johnson & Johnson, who owns DePuy, now faces over 10,000 injury claims***.

Now, in the first of those cases to go to trial, a jury has awarded a California man $8.3 million for damages related to his defective DePuy hip***.

Anyone who received a DePuy metal hip is urged to contact the DrugRisk Hip Center or speak with a lawyer about their full legal rights.

Due to the specialized nature of federal medical device injury cases, DrugRisk only recommends lawyers and law firms who have already handled DePuy hip lawsuits.

For more information on the DePuy hip recall, studies and litigation news related to implant or other metal hips, or to speak with a lawyer, visit http://www.DrugRisk.com.

*bmj.com/content/344/bmj.e1410
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm
***bloomberg.com/news/2013-03-08/j-j-must-pay-8-3-million-in-suit-over-defective-hip-jury-says.html
****medpagetoday.com/MeetingCoverage/AAOS/37984

Read the full story at http://www.prweb.com/releases/2013-depuy-hip-recall/lawsuit/prweb10610918.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... director. Mr. Still was selected through a careful months-long search by the RBMA Board ... to our members, has been a part of building the RBMA since 1992,” said ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Executives, Staff & Clients ... to for the Toys for Tots Literacy Campaign at their Semi-Annual Graduation and Fundraiser ... $70 billion, the U.S. ranks at number 14 internationally in literacy. Statistically, a direct ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... SkyLex Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon ... this procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Silicon Valley Hair ... to announce a new blog post about women’s hair loss. Although hair transplant procedures ... loss as they age. Menopause or genetics can be two reasons a woman may ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023" ... of the Chemotherapy Induced Neutropenia for the seven major markets i.e., ... ( France , Germany , ... Japan , as well as rest of ... The Report covers the therapeutics market revenue, treatment practice ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ - ... service medical device development firm, announced today that it ... Toronto -based medical device industrial design and productization ... companies throughout North America with ... device talent spanning the design, engineering, regulatory, and manufacturing ...
Breaking Medicine Technology: